Literature DB >> 26946082

Significance of IFN-ɤ/IL-2 Ratio as a Circulating Diagnostic Biomarker in Extrapulmonary Tuberculosis.

N Goyal1, B Kashyap2, I R Kaur1.   

Abstract

Extrapulmonary tuberculosis (EPTB) remains a challenging diagnosis both for clinicians and microbiologists. We hypothesized that the profile of IFN-ɤ/IL-2 ratio in clinically diagnosed cases of EPTB would be distinct from that of age- and sex-matched healthy controls. Therefore, in our study, we have assessed the ratio of serum levels of IFN-ɤ and IL-2 in clinically diagnosed cases of EPTB to assess their potential role as diagnostic biomarkers. Sixty-nine (69) clinically confirmed EPTB cases and 69 age- and sex-matched healthy controls were included in the study. All the extrapulmonary specimens were subjected to Ziehl-Neelsen staining for acid-fast bacilli and culture on Lowenstein-Jensen (LJ) medium. Detection of serum levels of IFN-ɤ and IL-2 was carried out using commercially available ELISA kits following manufacturers' instructions. The ratio of serum levels of IFN-ɤ and IFN-ɤ/IL-2 was discriminative for the diagnosis of EPTB cases (p < 0.001), although the same was not observed with IL-2 (p > 0.05). Distribution of all biomarkers significantly differed between culture-positive and culture-negative cases (p < 0.05). Among the smear-positive and smear-negative ones, only IFN-ɤ and IFN-ɤ/IL-2 ratio could significantly differentiate (p < 0.05). Ratio of IFN-ɤ and IL-2 rather than the individual levels was the best discriminatory biomarker with the highest area under the ROC curve. Although IFN-ɤ and IFN-ɤ/ IL-2 ratio could aid in the diagnosis of EPTB, IL-2 has a limited utility in the diagnosis of EPTB. Further elaborate studies to validate these results are required.
© 2016 The Foundation for the Scandinavian Journal of Immunology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26946082     DOI: 10.1111/sji.12424

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

1.  Comparative Diagnostic Utility of Neopterin and IFN-γ/IL-2 in Extrapulmonary Tuberculosis.

Authors:  Nisha Goyal; Bineeta Kashyap; N P Singh; Iqbal R Kaur
Journal:  Indian J Clin Biochem       Date:  2016-12-01

2.  Hesperidin methyl chalcone alleviates spinal tuberculosis in New Zealand white rabbits by suppressing immune responses.

Authors:  Yi Zhao; Yong Jiao; Lei Wang
Journal:  J Spinal Cord Med       Date:  2018-08-20       Impact factor: 1.985

3.  IL-18 and related function proteins associated with tuberculosis severity and screening for active TB among patients with non-mycobacterial community-acquired pneumonia (CAP).

Authors:  Sebastian Wawrocki; Michal Seweryn; Grzegorz Kielnierowski; Wieslawa Rudnicka; Magdalena Druszczynska
Journal:  Saudi J Biol Sci       Date:  2020-09-08       Impact factor: 4.219

4.  Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.

Authors:  Qin Sun; Wei Wei; Wei Sha
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

5.  Cytokine Biomarkers Associated with Human Extra-Pulmonary Tuberculosis Clinical Strains and Symptoms.

Authors:  Paulo Ranaivomanana; Mihaja Raberahona; Sedera Rabarioelina; Ysé Borella; Alice Machado; Mamy J De Dieu Randria; Rivo A Rakotoarivelo; Voahangy Rasolofo; Niaina Rakotosamimanana
Journal:  Front Microbiol       Date:  2018-02-21       Impact factor: 5.640

6.  Isoliquiritigenin attenuates spinal tuberculosis through inhibiting immune response in a New Zealand white rabbit model.

Authors:  Wenjing Wang; Baozhi Yang; Yong Cui; Ying Zhan
Journal:  Korean J Physiol Pharmacol       Date:  2018-06-25       Impact factor: 2.016

7.  IL-18/IL-37/IP-10 signalling complex as a potential biomarker for discriminating active and latent TB.

Authors:  Sebastian Wawrocki; Michal Seweryn; Grzegorz Kielnierowski; Wieslawa Rudnicka; Marcin Wlodarczyk; Magdalena Druszczynska
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

8.  Preliminary evaluation of a novel nine-biomarker profile for the prediction of autism spectrum disorder.

Authors:  Afaf El-Ansary; Wail M Hassan; Maha Daghestani; Laila Al-Ayadhi; Abir Ben Bacha
Journal:  PLoS One       Date:  2020-01-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.